Article
Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
Journal of hepatology - 1 Apr 2009
Kim Kyung-Ah, Lin Wenyu, Tai Andrew W, Shao Run-Xuan, Weinberg Ethan, De Sa Borges Carolina B, Bhan Atul K, Zheng Hui, Kamegaya Yoshitaka, Chung Raymond T
Abstract excerpt
BACKGROUND/AIMS: The response rates of HCV infection to interferon therapy vary depending on viral and host factors. We hypothesized that key regulators of the IFN signaling pathway are predictive of treatment outcome. METHODS: We measured the expression of signal transducer and activator of transcription 1 (STAT1) and suppressor of cytokine signaling 3 (SOCS3) in pretreatment liver biopsies. Staining...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
